DRKS00033100RecruitingNot Applicable
Analysis of anti-tumor-effects of ?d T cells on cancer cells
Klinikum Nürnberg - Hämatologie/Onkologie0 sites125 target enrollmentStarted: November 24, 2023Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 125
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Healthy donors:
- •- Written consent
- •Patients with haematological neoplasms:
- •- Written consent
- •- Medical indication for sampling
Exclusion Criteria
- •Healthy donors:
- •- current illness
- •- Previous donation for the same (sub-)project
- •- Previous donation within the last 3 months
- •Patients with haematological neoplasms:
- •- unreasonable burden by additional sampling
- •- assumed risk by additional sampling
- •- delay of clinical diagnostics or therapy by study inclusion
Investigators
Similar Trials
Completed
Not Applicable
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant RadiochemotherapyHead and Neck CancerLung CancerNCT03117946Centre Hospitalier Universitaire de Besancon136
Recruiting
Not Applicable
Investigation of drug specific cytotoxic T cell in severe cutaneous adverse drug reactioJPRN-UMIN000009708Yokohama City University Graduate School of Medicine10
Completed
Not Applicable
ongitudinal analysis of tumor-specific T-cel immunity in irresectable stage IIIc and stage IV melanoma patientsskin cancermelanoma10040900NL-OMON36481eids Universitair Medisch Centrum50
Completed
Phase 2
Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)Non Small Cell Lung CancerNCT01820754Duke University24
Not yet recruiting
Not Applicable
Antitumor T Cell Responses in Patients With Bladder CancerBladder CancerNCT06334406Centre Hospitalier Universitaire de Besancon33